5

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: February 13, 2012
Period of Report: December 31, 2011
Accession Number: 0001237899-12-000023

View Document ↗ View on SEC.gov ↗